Capital International, Inc./CA/ - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International, Inc./CA/ ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$6,768,456
-30.3%
2,942,807
-2.4%
0.15%
-32.7%
Q3 2022$9,713,000
-41.0%
3,016,371
+0.8%
0.22%
-4.8%
Q2 2022$16,465,000
+202.6%
2,993,695
+28.2%
0.23%
+273.8%
Q1 2022$5,442,000
-48.5%
2,335,476
+33.4%
0.06%
-37.8%
Q4 2021$10,574,000
-34.3%
1,750,707
+50.8%
0.10%
-36.8%
Q3 2021$16,102,000
+24.2%
1,160,891
+16.4%
0.16%
+33.6%
Q2 2021$12,964,000
-4.6%
997,238
+13.0%
0.12%
-7.9%
Q1 2021$13,595,000882,7680.13%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 10,881,144$31,337,6953.43%
Sio Capital Management, LLC 2,081,216$5,993,9021.86%
Pivotal bioVenture Partners Investment Advisor LLC 1,375,000$3,960,0001.58%
TCG Crossover Management, LLC 3,038,889$8,752,0001.29%
Logos Global Management LP 2,525,000$7,272,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 1,531,497$4,410,7110.80%
Orbimed Advisors 9,308,726$26,809,1310.57%
GREAT POINT PARTNERS LLC 579,667$1,669,4410.30%
Temasek Holdings (Private) Ltd 9,901,940$28,517,5870.17%
TANG CAPITAL MANAGEMENT LLC 159,087$458,1710.06%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders